Health Headlines for Tuesday, April 11

Trump Administration to Pay Health Law Subsidies Disputed by House

New York Times

The Trump administration says it is willing to continue paying subsidies to health insurance companies under the Affordable Care Act even though House Republicans say the payments are illegal because Congress never authorized them.

Read Full Article


Is Obamacare in a ‘Death Spiral’?

Politico

The Affordable Care Act’s marketplaces have faced a tough year.

Read Full Article


$150 million in state budget for new health lab in Albany area

Albany Business Review

The new lab will develop life science research, innovation and infrastructure through a joint effort between Empire State Development and the Department of Health.

Read Full Article


How bad is pharmaceutical pollution in the Hudson?

NorthJersey.com

Scientists are taking samples of the Hudson River this month in an ambitious plan to measure how much pharmaceutical pollution gets washed into the waterway during heavy rains and to pinpoint its source.

Read Full Article


Addicts Who Can’t Get Opioids Are Overdosing on a Diarrhea Drug

The Atlantic

Opioid painkillers have an inconvenient, lesser-known side effect: terrible constipation.

Read Full Article


Nevada advocates try again to ban surprise medical bills

Albany Times Union/AP

Alarmingly expensive medical bills came under fire at the Nevada Legislature on Monday, six years after Gov. Brian Sandoval shot down a proposal that similarly attempted to ban surprise out-of-network costs.

Read Full Article


Senate approves high-deductible plans in insurance bill

Albany Times Union/AP

Hawaii lawmakers have approved legislation that would allow employers to offer employees a high-deductible health insurance plan that’s paired with a savings account.

Read Full Article


Why Are So Many People Popping Vitamin D?

New York Times

There was no reason for the patients to receive vitamin D tests.

Read Full Article


The federal panel that opposed prostate cancer screening just changed its mind

Washington Post

An influential federal task force has dropped its controversial opposition to routine screening for prostate cancer and now says that men between the ages of 55 and 69 should discuss the test’s potential benefits and harms with their doctors and make decisions based on their own “values and preferences.”

Read Full Article


Doctors still divided on when women should start mammograms

PIX11

Despite what the American Cancer Society and other health organizations advise, many doctors still recommend routine mammograms to screen for breast cancer in younger and older women, a new paper suggests.

Read Full Article